TP53 and acute myeloid leukemia: There was no association between these transcriptional profiles and mutations in AML related genes, cytogenetics or ELN genetic risk categories such as the presence of NPM1, FLT3-ITD, TP53, RUNX1 or ASXL1 mutations.